Prostate Cancer Testing Market Size, Share, Growth, and Industry Analysis, By Type (PSA Tests,CTC Tests,Immunohistochemistry,PCA3 Tests), By Application (Hospital Associated Labs,Independent Diagnostic Laboratories,Cancer Research Institutes), Regional Insights and Forecast to 2035

Detailed TOC of Global Prostate Cancer Testing Market Growth (Status and Outlook) 2024-2030

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostate Cancer Testing Market Size 2019-2030
2.1.2 Prostate Cancer Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Prostate Cancer Testing Segment by Type
2.2.1 PSA Tests
2.2.2 CTC Tests
2.2.3 Immunohistochemistry
2.2.4 PCA3 Tests
2.2.5 Others
2.3 Prostate Cancer Testing Market Size by Type
2.3.1 Prostate Cancer Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Prostate Cancer Testing Market Size Market Share by Type (2019-2024)
2.4 Prostate Cancer Testing Segment by Application
2.4.1 Hospital Associated Labs
2.4.2 Independent Diagnostic Laboratories
2.4.3 Cancer Research Institutes
2.4.4 Others
2.5 Prostate Cancer Testing Market Size by Application
2.5.1 Prostate Cancer Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Prostate Cancer Testing Market Size Market Share by Application (2019-2024)
3 Prostate Cancer Testing Market Size by Player
3.1 Prostate Cancer Testing Market Size Market Share by Players
3.1.1 Global Prostate Cancer Testing Revenue by Players (2019-2024)
3.1.2 Global Prostate Cancer Testing Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Cancer Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Prostate Cancer Testing by Regions
4.1 Prostate Cancer Testing Market Size by Regions (2019-2024)
4.2 Americas Prostate Cancer Testing Market Size Growth (2019-2024)
4.3 APAC Prostate Cancer Testing Market Size Growth (2019-2024)
4.4 Europe Prostate Cancer Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Prostate Cancer Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Prostate Cancer Testing Market Size by Country (2019-2024)
5.2 Americas Prostate Cancer Testing Market Size by Type (2019-2024)
5.3 Americas Prostate Cancer Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate Cancer Testing Market Size by Region (2019-2024)
6.2 APAC Prostate Cancer Testing Market Size by Type (2019-2024)
6.3 APAC Prostate Cancer Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Prostate Cancer Testing by Country (2019-2024)
7.2 Europe Prostate Cancer Testing Market Size by Type (2019-2024)
7.3 Europe Prostate Cancer Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prostate Cancer Testing by Region (2019-2024)
8.2 Middle East & Africa Prostate Cancer Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Prostate Cancer Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Prostate Cancer Testing Market Forecast
10.1 Global Prostate Cancer Testing Forecast by Regions (2025-2030)
10.1.1 Global Prostate Cancer Testing Forecast by Regions (2025-2030)
10.1.2 Americas Prostate Cancer Testing Forecast
10.1.3 APAC Prostate Cancer Testing Forecast
10.1.4 Europe Prostate Cancer Testing Forecast
10.1.5 Middle East & Africa Prostate Cancer Testing Forecast
10.2 Americas Prostate Cancer Testing Forecast by Country (2025-2030)
10.2.1 United States Prostate Cancer Testing Market Forecast
10.2.2 Canada Prostate Cancer Testing Market Forecast
10.2.3 Mexico Prostate Cancer Testing Market Forecast
10.2.4 Brazil Prostate Cancer Testing Market Forecast
10.3 APAC Prostate Cancer Testing Forecast by Region (2025-2030)
10.3.1 China Prostate Cancer Testing Market Forecast
10.3.2 Japan Prostate Cancer Testing Market Forecast
10.3.3 Korea Prostate Cancer Testing Market Forecast
10.3.4 Southeast Asia Prostate Cancer Testing Market Forecast
10.3.5 India Prostate Cancer Testing Market Forecast
10.3.6 Australia Prostate Cancer Testing Market Forecast
10.4 Europe Prostate Cancer Testing Forecast by Country (2025-2030)
10.4.1 Germany Prostate Cancer Testing Market Forecast
10.4.2 France Prostate Cancer Testing Market Forecast
10.4.3 UK Prostate Cancer Testing Market Forecast
10.4.4 Italy Prostate Cancer Testing Market Forecast
10.4.5 Russia Prostate Cancer Testing Market Forecast
10.5 Middle East & Africa Prostate Cancer Testing Forecast by Region (2025-2030)
10.5.1 Egypt Prostate Cancer Testing Market Forecast
10.5.2 South Africa Prostate Cancer Testing Market Forecast
10.5.3 Israel Prostate Cancer Testing Market Forecast
10.5.4 Turkey Prostate Cancer Testing Market Forecast
10.5.5 GCC Countries Prostate Cancer Testing Market Forecast
10.6 Global Prostate Cancer Testing Forecast by Type (2025-2030)
10.7 Global Prostate Cancer Testing Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Genomic Health
11.1.1 Genomic Health Company Information
11.1.2 Genomic Health Prostate Cancer Testing Product Offered
11.1.3 Genomic Health Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Genomic Health Main Business Overview
11.1.5 Genomic Health Latest Developments
11.2 OPKO
11.2.1 OPKO Company Information
11.2.2 OPKO Prostate Cancer Testing Product Offered
11.2.3 OPKO Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 OPKO Main Business Overview
11.2.5 OPKO Latest Developments
11.3 Siemens Healthcare
11.3.1 Siemens Healthcare Company Information
11.3.2 Siemens Healthcare Prostate Cancer Testing Product Offered
11.3.3 Siemens Healthcare Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Siemens Healthcare Main Business Overview
11.3.5 Siemens Healthcare Latest Developments
11.4 DiaSorin
11.4.1 DiaSorin Company Information
11.4.2 DiaSorin Prostate Cancer Testing Product Offered
11.4.3 DiaSorin Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 DiaSorin Main Business Overview
11.4.5 DiaSorin Latest Developments
11.5 bioMeriux
11.5.1 bioMeriux Company Information
11.5.2 bioMeriux Prostate Cancer Testing Product Offered
11.5.3 bioMeriux Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 bioMeriux Main Business Overview
11.5.5 bioMeriux Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Prostate Cancer Testing Product Offered
11.6.3 Roche Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 MDx Health
11.7.1 MDx Health Company Information
11.7.2 MDx Health Prostate Cancer Testing Product Offered
11.7.3 MDx Health Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 MDx Health Main Business Overview
11.7.5 MDx Health Latest Developments
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Information
11.8.2 Beckman Coulter Prostate Cancer Testing Product Offered
11.8.3 Beckman Coulter Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Beckman Coulter Main Business Overview
11.8.5 Beckman Coulter Latest Developments
11.9 Myriad Genetics
11.9.1 Myriad Genetics Company Information
11.9.2 Myriad Genetics Prostate Cancer Testing Product Offered
11.9.3 Myriad Genetics Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Myriad Genetics Main Business Overview
11.9.5 Myriad Genetics Latest Developments
11.10 Ambry Genetics
11.10.1 Ambry Genetics Company Information
11.10.2 Ambry Genetics Prostate Cancer Testing Product Offered
11.10.3 Ambry Genetics Prostate Cancer Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Ambry Genetics Main Business Overview
11.10.5 Ambry Genetics Latest Developments